| Pharmaceutical active ingredients: |
| Granisetron |
| Available forms, composition and doses of Granicip: |
| Injectable; Injection; Granisetron 1 mg / mlInjectable; Injection; Granisetron 3 mg / mlTablets; Oral; Granisetron 1 mgTablets; Oral; Granisetron 2 mg |
| Granicip medical category: |
| Human:5-HT3 Receptor AntagonistsAntiemeticsSupportive care therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A04AA02 - Granisetron |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Cipla |